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ABSTRACT    28 
Chronic alcohol consumption promotes mitochondrial dysfunction, oxidative stress, 29 
defective protein metabolism, and fat accumulation in hepatocytes (liver steatosis). 30 
Inadequate amino-acid metabolism is worsened by protein malnutrition, frequently 31 
present in alcohol-consuming patients, with reduced circulating branched-chain 32 
amino acids (BCAAs). Here we asked whether dietary supplementation with a 33 
specific amino-acid mixture, enriched in BCAAs (BCAAem) and able to promote 34 
mitochondrial function in muscle of middle-aged rodents, would prevent 35 
mitochondrial dysfunction and liver steatosis in Wistar rats fed on a Lieber-DeCarli 36 
ethanol (EtOH)-containing liquid diet. Supplementation of BCAAem, unlike a 37 
mixture based on the amino acid profile of casein, abrogated the EtOH-induced fat 38 
accumulation, mitochondrial impairment, and oxidative stress in liver. These effects 39 
of BCAAem were accompanied by normalization of leucine, arginine, and tryptophan 40 
levels, which were reduced in liver of EtOH-consuming rats. Moreover, while the 41 
EtOH exposure of HepG2 cells reduced mitochondrial DNA, mitochondrial 42 
transcription factors, and respiratory chain proteins, the BCAAem but not casein-43 
derived amino acid supplementation halted this mitochondrial toxicity. Nicodinamide 44 
adenine dinucleotide levels and sirtuin 1 expression, as well as endothelial nitric 45 
oxide (eNOS) and mammalian/mechanistic target of rapamycin (mTOR) signaling 46 
pathways, were down-regulated in the EtOH-exposed HepG2 cells. BCAAem 47 
reverted these molecular defects and the mitochondrial dysfunction, suggesting that 48 
the mitochondrial integrity obtained with the amino acid supplementation could be 49 
mediated through a Sirt1-eNOS-mTOR pathway. Thus, a dietary activation of the 50 
mitochondrial biogenesis and function by a specific amino acid supplement protects 51 
against the EtOH toxicity and preserves the liver integrity in mammals.  52 
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NEW & NOTEWORTHY 53 
Dietary supplementation of a specific amino acid formula prevents both fat 54 
accumulation and mitochondrial dysfunction in hepatocytes of alcohol-consuming 55 
rats. These effects are accompanied also by increased expression of anti-ROS genes. 56 
The amino-acid protective effects likely reflect activation of Sirt1-eNOS-mTOR 57 
pathway able to regulate the cellular energy balance of hepatocytes exposed to 58 
chronic, alcoholic damage.  59 
 60 
KEYWORDS: alcoholic liver disease; branched-chain amino acids; endothelial nitric 61 
oxide synthase; mechanistic target of rapamycin; mitochondrial biogenesis. 62 
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INTRODUCTION 63 
An excessive and chronic alcohol consumption may cause alcoholic liver disease 64 
(ALD), a major global health problem (68). ALD is a spectrum of liver pathologies 65 
mainly characterized by fat accumulation, and ranging from steatosis to 66 
steatohepatitis, fibrosis, and cirrhosis which can eventually progress to hepatocellular 67 
carcinoma (47). In particular, the early stages of the disease are associated with 68 
vesicular steatosis, caused by defective fatty acid oxidation (13). All of the alcohol-69 
metabolizing enzymes, including alcohol dehydrogenase, catalase, NADPH-oxidase, 70 
xantine oxidase, and the microsomal alcohol oxidizing system, lead to acetaldehyde 71 
accumulation in liver. Acetaldehyde can be oxidized to acetate, mainly through 72 
aldehyde dehydrogenases, which are mitochondrial, nicotinamide dinucleotide 73 
(NAD
+
)-dependent enzymes, so that the concentration of the reduced pyridine 74 
coenzyme NADH increases, and the NAD
+
/NADH ratio decreases in hepatocytes. 75 
Such an imbalance has been classically proposed to explain several  of the metabolic 76 
changes produced directly in liver cells by alcohol oxidation, including triglyceride 77 
accumulation (18). Similarly, sirtuin 1 (Sirt1), a NAD
+
-dependent protein deacetylase 78 
that removes post-traslational acyl modifications from various cellular substrates to 79 
regulate a wide range of biological pathways (14), was found to be reduced in liver of 80 
alcohol-consuming animals (49). Sirt1 controls hepatic gluconeogenesis/glycolytic 81 
processes and mitochondrial biogenesis, through peroxisome proliferator-activated 82 
receptor  coactivator 1  (PGC-1) (56, 80). Moreover, Lieber and co-workers have 83 
demonstrated that Sirt1 and PGC-1, acting as a complex, can physiologically 84 
regulate each others’ activity in liver of alcohol-consuming animals (49). 85 
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Although the adverse effects of excessive alcohol consumption on liver mitochondria 86 
are well known (11, 32), the molecular impairment impinging on the  alcohol-87 
dependent mitochondrial dysfunction remains to be defined. Incapacity to maintain 88 
adequate ATP concentrations, associated to reduced activities of all of the respiratory 89 
complexes (except complex II) (22), impaired mitochondrial protein synthesis (17), in 90 
addition to mitochondrial DNA (mtDNA) damage (12) and ribosomal defects (10), 91 
have been suggested to cause failing oxidative phosphorylation. These processes 92 
increase reactive oxygen species (ROS) production and oxidative damage in the 93 
steatotic liver, accompanied by a marked mitochondrial dysfunction (54).  94 
 95 
Beyond their role as key building blocks for protein synthesis, amino acids, 96 
particularly the branched-chain amino acids (BCAAs), are also significant sources of 97 
sterol, ketone bodies, and glucose (9). Mammalian/mechanistic target of rapamycin 98 
(mTOR) complex 1 (mTORC1), which is acutely sensitive to rapamycin and amino 99 
acid availability, mediates some of these processes (84). We have recently shown that 100 
dietary supplementation with a BCAA-enriched mixture (BCAAem) activated 101 
endothelial nitric oxide synthase (eNOS) with increased NO production in cardiac 102 
and skeletal muscle of middle-aged mice (23). Notably, the BCAAem-induced NO 103 
promoted mTORC1-dependent mitochondrial biogenesis and function in muscle cells 104 
(23). Because altered amino acid metabolism is a hallmark of ALD, with low levels 105 
of circulating BCAAs (15), the present study aimed to investigate the effects of 106 
BCAAem supplementation on the mitochondrial damage in liver of chronically 107 
ethanol (EtOH)-consuming rats. Our results demonstrate that this specific amino acid 108 
supplementation was able to prevent both structural mitochondrial damage and 109 
mitochondrial dysfunction in liver of alcoholic rats. We found that anti-ROS defense 110 
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system, eNOS, and mTOR pathways likely play an important role in the protective 111 
effects of dietary BCAAem supplementation in hepatic cells. Together, our results 112 
support the potential usefulness of dietary supplementation with a specific amino acid 113 
formula to prevent the alcoholic liver disease in humans. 114 
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MATERIALS AND METHODS 115 
Animals and Treatments 116 
The experimental protocol was approved and conducted in accordance with the 117 
European Communities Council Directive of November 24, 1986 (86/609/EEC), and 118 
the Italian Ministry of Heath, and complied with The National Animal Protection 119 
Guidelines. For experiment #1, a total of 26 male Wistar rats (3 months old) from 120 
Charles River (Calco, Como, Italy) were used. The animals were housed separately 121 
in clean polypropylene cages and divided into four groups: 1) the pair-fed group 122 
(pair-fed CTRL, n = 6), was fed with a control liquid diet, in which EtOH was 123 
replaced by isocaloric maltose dextran; 2) the EtOH group (EtOH, n = 7), was fed 124 
with a Lieber-DeCarli liquid diet containing EtOH ad libitum [gradually increasing 125 
amount of EtOH, reaching 36 % of caloric intake after 1 week, corresponding to a 126 
final concentration of 6.2 % (vol/vol)]; 3) the BCAAem group (BCAAem, n = 6), 127 
fed with a control liquid diet, in which EtOH was replaced by isocaloric maltose 128 
dextran, and supplemented with branched-chain amino acid mixture (10 g/L), that 129 
provided 1.5 g/kg/day BCAAem; and 4) the EtOH plus BCAAem group (EtOH + 130 
BCAAem, n = 7), fed with a Lieber-DeCarli liquid diet containing EtOH and 131 
BCAAem ad libitum. For experiment #2, a total of 30 male Wistar rats (3 months 132 
old) were divided into five groups: 1) the pair-fed group (CTRL, n = 6), 2) the EtOH 133 
group (EtOH, n = 6), and 3) the EtOH plus BCAAem group (n = 6) were fed as in 134 
Experiment #1; 4) the casein-amino acid group (CAA, n = 6), fed with a control 135 
liquid diet, in which EtOH was replaced by isocaloric maltose dextran, and 136 
supplemented with purified amino acid mixture based on the amino acid profile of 137 
casein (10 g/L) (which is the main protein source in rodent laboratory diet), that 138 
provided 1.5 g/kg/day CAA supplement; and 5) the EtOH plus CAA group (EtOH + 139 
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CAA, n = 6), fed with a Lieber-DeCarli liquid diet containing EtOH and CAA 140 
mixture ad libitum. All of the diets were isocaloric with each other, and they were 141 
obtained from Bio-Serv, Frenchtown, NJ, USA. The composition of each diet is 142 
described in Table 1. The amino acid concentrations of BCAAem used was 143 
previously found to be active in rodents and mimic the recommended daily dose for 144 
humans (23). Dietary treatments were prolonged for 8 weeks, in a 12 h light/12 h 145 
dark cycle at 22 °C, in a quiet, temperature- and humidity-controlled room. The 146 
BCAAem composition, amino acid relative percentage, and dietary intake of each 147 
amino acid have been reported in D’Antona et al. (24). Body weight and food intake 148 
were recorded twice a week. At the end, animals were sacrified by guillotine. Left 149 
lobe of liver was fixed for microscopy analysis, while the rest of the organ was 150 
quickly frozen in liquid nitrogen and stored at – 80 °C for subsequent analysis (see 151 
below). 152 
 153 
Sample Preparation 154 
Liver (n = 4 animals/group) was weighted, homogenized in cold methanol:water 155 
(v/v, 1:1), and extracted according to Want et al. (76). The vacuum dried samples 156 
were suspended in 120 µl/50 mg tissue of methanol:1 mM TDFHA = 1:1 and 157 
centrifuged at 16,000 g for 10 minutes at 4 °C. Two µl of surnatant were directly 158 
loaded onto the UPLC-mass spectrometer and analyzed as reported below. Four 159 
technical replicates for each sample were run using the three different methods. 160 
 161 
Chromatography and amino acid quantification in liver 162 
Standard amino acids were purchased from Sigma (Milan, Italy). Each amino acid 163 
stock solutions were prepared at 1 mg/ml in water, diluted to the final concentration 164 
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of 3 pmol/µl, and directly infused by syringe at 10 µl/min into the TripleTOF 5600
+
 165 
mass spectrometer (AB Sciex, Milan, Italy). Thus, declustering potential (DP) and 166 
collision energy (CE) were optimized for each amino acid. Next, three mixtures of 167 
amino acids were prepared on the basis of DP and CE values: MIX 1, containing 168 
threonine, asparagine, tyrosine, and serine, and analyzed with DP: 30 V, CE: 15 V; 169 
MIX 2, containing glycine, alanine, leucine, isoleucine, valine, proline, histidine, 170 
methionine, aspartic acid, glutamine, and phenylalanine, and analyzed with DP: 40 171 
V, CE: 15 V; and MIX 3, containing glutamic acid, lysine, arginine, and tryptophan, 172 
and analyzed with  DP: 80 V, CE: 18 V.  All of the amino acids were acquired in the 173 
positive polarity, in both TOF MS and Product Ion mode, according to the m/z 174 
values reported in Table 2.  The source parameters were: gas 1: 33 psi, gas 2: 58 psi, 175 
curtain gas: 25 psi, temperature: 500 °C, and ISVF (IonSpray Voltage Floating): 176 
5500 V. In order to obtain calibration curves, technical quadruplicates of different 177 
amounts (10, 33, 50, 100, 200, 400 pmol) of the three mixtures were injected into 178 
the mass spectrometer upon UPLC separation, using the UPLC 1290 (Agilent 179 
Technologies Italia, Cernusco sul Naviglio, Milan, Italy). The chromatographic 180 
column was from Waters, Acquity HSS T3 C18 2.1 x 100 mm, 1.7 µm, while the 181 
mobile phase was A: 1 mM TDFHA (tridecafluoroheptanoic acid) in water; B: 1 182 
mM TDFHA in acetonitrile. A gradient of B from 12.5 % to 26.5 % in 4 min, 183 
followed by a ramp from 26.5 to 92 % in 3.5 min was used to separate all of the 184 
amino acids, with a flow rate of 0.35 ml/min and a column temperature of 65°C as 185 
described (43). The autosampler was set at 4 °C. Calibration curves were plotted 186 
using chromatographic peak areas and a weighted regression (1/x for all compounds 187 
except asparagine, tyrosine, valine, and glutamic acid, which were fit to 1/x
2
) by 188 
means of MultiQuant software version 2.1 (SCIEX). Quantitative values for each 189 
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amino acid (pmol) in the rat liver samples were obtained by relating 190 
chromatographic peak areas to those derived from externally run calibration 191 
standards and normalized to tissue (mg). 192 
 193 
Liver Histopathological Analysis 194 
Liver was cut in 5-mm-thick slices and fixed in 4 % paraformaldehyde for 24 h and 195 
processed for paraffin embedding. Sections were stained with haematoxylin and 196 
eosin (H&E).  197 
 198 
Transmission Electron Microscopy Analysis 199 
Liver was removed, fixed with 2.5 % glutaraldehyde in cacodylate buffer (pH 7.4, 200 
0.2M), and post-fixed for 1 h with 1 % OsO4 in the same buffer. The samples were 201 
processed with standard procedures for embedding in Araldite (Sigma-Aldrich 202 
Chemical Co, Milan, Italy) and polymerized at 60 °C for 72 h. Thick sections (about 203 
1 µm) were stained with Epoxy Tissue Stain (#14950, Electron Microscopy Sciences, 204 
PA, USA). Ultrathin sections (70 nm) were stained with a saturated aqueous solution 205 
of uranyl acetate and lead citrate and examined with a Philips CM10 electron 206 
microscope (Royal Philips Electronics, Amsterdam, the Netherlands) at 80 KV. On 207 
thin sections, ultrastructural data on mitochondria from perivenous central area were 208 
collected from 18 randomly selected areas from each sample at a final enlargement of 209 
x5000 using electron microscope film (Kodak electron film 4489, 6.5x9 cm, New 210 
York, USA). Five different section levels of each sample were examined. The total 211 
area examined was about 140,000.00 µm
2
 in each group. We have previously shown 212 
that cytochrome c oxidase and peroxisome staining were markedly reduced, while 213 
markers of endoplasmic reticulum stress and inflammation were markedly increased 214 
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mainly in the perivenous central hepatocytes of the EtOH-consuming rats (20). For 215 
this reason we have focused the present analysis on the perivenous central 216 
hepatocytes. All measurements were obtained using standard morphometric 217 
techniques, as previously described (20, 77). Cytoplasmic (Acyt) and mitochondrial 218 
(Amit) area, the Amit to Acyt ratio (Amit/Acyt), and the number of mitochondria over 219 
100 μm2 of cytoplasm (i.e., the mitochondrial density; Nmit/100 μm2) were measured.  220 
 221 
Cell Culture and Treatment 222 
Human HCC HepG2 cells were purchased from the American Type Culture 223 
Collection (HB-8065; ATCC, Manassas, VA). Cells were routinely cultured in 224 
RPMI-1640 medium, supplemented with 10 % fetal bovine serum, penicillin (100 225 
U/mL), and streptomycin (100 μg/mL), in an atmosphere with 5 % CO2 at 37 °C. 226 
Two million HepG2 cells were seeded per 75 cm
2
 flask (Corning Inc., Corning, NY). 227 
Six h after seeding, 75 mM (0.34 %) EtOH and 1 % BCAAem (or CAA mixture) 228 
were added, alone or in combination. Untreated cells were plated as controls. Every 229 
24 h, media were replaced in both control and treatment flasks, with fresh media, with 230 
or without EtOH and BCAAem, respectively. Four days after seeding, cells were 231 
trypsinized and seeded into new flasks, at 2 million viable cells per flask, with daily 232 
media changes, as described before (64). Five days after the split process (a total of 9 233 
days with or without EtOH, BCAAem, CAA mixture, or EtOH plus BCAAem or 234 
CAA mixture), the cells were harvested as reported below for the different assays.  235 
 236 
Moreover, HepG2 cells were seeded in 6-well plates and treated each day with 100 237 
nM rapamycin, a macrolide compound that inhibits mTOR signaling, or with 5 M 238 
1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one (ODQ), the soluble guanylyl cyclase 239 
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inhibitor, 1 h before BCAAem (1 %) addition, and 6 h before 100 mM EtOH 240 
treatment (48 h) (28). Vehicle-treated cells were exposed to 0.02 % dimethyl 241 
sulfoxide (DMSO) for 48 h. Furthermore, eNOS knockdown was obtained with 242 
transient transfection of small interference RNA (siRNA). HepG2 cells were seeded 243 
in 6-well plates and transfected with 100 nmol/l eNOS siRNA SMARTpool 244 
(Dharmacon, Lafayette, CO) or siCONTROL nontargeting siRNA using Dharmafect 245 
transfection reagent. After 48 h transfection, the cells were then treated with 1 % 246 
BCAAem and 100 mM EtOH for 48 h. Efficacy of transfection was determined using 247 
siGLO-RISC-free nontargeting siRNA and estimation of siRNA uptake by 248 
fluorescence detection (absorbance/emission 557/570). Proteins were extracted for 249 
Western blotting analysis.  250 
 251 
Oil Red O Staining 252 
HepG2 cells were washed twice with DPBS and fixed with 10 % formalin for 1 h. 253 
Then, they were stained with 0.3 % Oil Red O in 60 % isopropanol for 2 h at room 254 
temperature. The cells were subsequently washed three times with distilled water. Fat 255 
droplets were dissolved with 100 % propanol, and quantified by measuring the optical 256 
absorbance at a wavelength of 510 nm, using a Biorad Model 680 microplate reader 257 
(66). 258 
 259 
Quantitative RT-PCR Analysis 260 
Quantitative RT-PCR reactions were performed as described (73) and run with the iQ 261 
SybrGreenI SuperMix (Bio-Rad; Segrate, Italy) on an iCycler iQ Real-Time PCR 262 
detection system (Bio-Rad). Briefly, RNA was isolated from tissue using the 263 
RNeasy
®
 Tissue Mini Kit (Qiagen, Milan, Italy). cDNA was synthesized using 264 
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iScript
TM
 cDNA Synthesis Kit (Bio-Rad Laboratories, Segrate, Italy). Primers were 265 
designed using Beacon Designer 2.6 software from Premier Biosoft International (see 266 
Tables 3 and 4). The cycle number at which the various transcripts were detectable 267 
(threshold cycle, CT) was compared to that of TBP, referred to as ΔCT. The gene 268 
relative levels were expressed as 2
-(ΔΔCT), in which ΔΔCT equals ΔCT of EtOH- or 269 
BCAAem- or CAA mixture-treated rat (or treated HepG2 cells) minus ΔCT of the 270 
control rat (or untreated HepG2 cells). 271 
 272 
Western Blot Analysis 273 
Protein extracts were obtained from liver with T-PER Mammalian Protein Extraction 274 
Reagent (Pierce, ThermoScientific, Rockford, USA) as described by the 275 
manufacturer, in the presence of protease and phosphatase  inhibitors cocktail (Sigma 276 
Aldrich, Milan, Italy). Protein content was measured by the bicinchoninic acid protein 277 
assay (BCA, Pierce, Euroclone, Milan, Italy), and 50 µg of proteins were run on SDS-278 
PAGE under reducing conditions. The separated proteins were then 279 
electrophoretically transferred to a nitrocellulose membrane (Bio-Rad Laboratories, 280 
Segrate, Italy). Proteins of interest were revealed with specific antibodies: anti-COX 281 
IV (cytochrome c oxidase subunit IV), anti-Cyt c (cytochrome complex),  anti-p-282 
eNOS (Ser1177-phospho-eNOS),  anti-acetyl p53, anti-p-Akt (Ser473-phospho-Akt), 283 
anti-Akt, anti-p-p70 S6 kinase (Thr389-phospho-p70S6kinase), anti-p70 S6 Kinase, 284 
anti-Sirt1, anti--actin (all from Cell Signaling, Euroclone, Milan, Italy), anti-eNOS 285 
(Santa Cruz, CA, USA), anti-p53 (from GeneSpin, Milan, Italy), anti-SOD1 286 
(superoxide dismutase [Cu-Zn], from Santa Cruz, CA, USA), anti-catalase (from 287 
Santa Cruz, CA, USA), at 1:1000 dilution each one. The immunostaining was 288 
detected using horseradish peroxidase-conjugated anti-rabbit or anti-mouse 289 
Downloaded from www.physiology.org/journal/ajpgi by ${individualUser.givenNames} ${individualUser.surname} (159.149.103.006) on February 20, 2018.
Copyright © 2018 American Physiological Society. All rights reserved.
 14 
immunoglobulin for 1 h at room temperature. After the visualization of p-eNOS, 290 
acetyl p53, p-Akt, and p-p70 S6 kinase, filters were stripped with the Restore
TM
 291 
Western Blot Stripping Buffer (Euroclone, Milan, Italy) and further used for the 292 
visualization of total eNOS, total p53, total Akt, or total p70 S6 kinase. The amount 293 
of protein was measured using SuperSignal Substrate (Pierce, Euroclone, Milan, 294 
Italy), and quantified by densitometry with IMAGEJ software image analyser.  295 
 296 
Mitochondrial DNA Measurement 297 
For mtDNA analysis, total DNA was extracted with QIAamp DNA extraction kit 298 
(Qiagen). The content of mtDNA was calculated using Real-Time quantitative PCR 299 
by measuring the threshold cycle ratio (ΔCT) of a mitochondrial encoded gene 300 
NADH dehydrogenase subunit 1 (ND1) vs. a nuclear encoded gene (-Globin) in 301 
liver of EtOH-, BCAAem-, or CAA mixture-treated and control (CTRL) rats, as 302 
described (27). 303 
 
Citrate Synthase Activity Measurement 304 
The citrate synthase activity was measured spectrophotometrically at 412 nm at 30 °C 305 
in liver tissue extracts (51). Liver samples were added to a buffer containing 0.1 mM 306 
5,5−dithio−bis−(2−nitrobenzoic) acid, 0.5 mM oxaloacetate, 50 M EDTA, 0.31 mM 307 
acetyl CoA, 5 mM triethanolamine hydrochloride, and 0.1 M Tris-HCl, pH 8.1. 308 
Citrate synthase activity was expressed as nmol citrate produced per min per mg of 309 
protein. The data were normalized to total protein content, determined as reported 310 
above. 311 
 312 
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NAD
+
and NADH Measurement 313 
NAD
+
 and NADH levels were measured by enzymatic NADH recycling assay, using 314 
the NAD
+
/NADH Quantification kit from Biovision (Vinci-Biochem, Florence, 315 
Italy), according to the manufacturer’s recommendations. Liver samples were 316 
homogenized in 400 µl of NAD
+
/NADH extraction buffer, and filtered using 317 
Microcon YM-10 (GE Healthcare, Euroclone, Milan, Italy). Then, the samples were 318 
split into two sets, one of which was used to carry out the thermal decomposition of 319 
NAD
+
, followed by the cycling assay for the determination of NADH content. The 320 
other set was used to measure the total NADH plus NAD
+
 content, by performing the 321 
cycling assay without the thermal decomposition. Then, the NAD
+
/NADH ratio was 322 
calculated. The data were normalized by total protein content (see above). 323 
 324 
Mitochondrial Oxidative Stress 325 
To measure the oxidative damage of DNA, the highly sensitive 8-hydroxy-2’-326 
deoxyguanosine (8-OHdG) Check ELISA Kit (JalCA) was used (24). Measurements 327 
were carried out in accordance with the manufacturer’s protocol. Total DNA was 328 
extracted using QIampDNAMini Kit (Qiagen), and digested with nuclease P1 and 329 
alkaline phosphatase (Sigma-Aldrich, Milan, Italy). Quality and quantity of DNA 330 
were confirmed by a NanoDrop ND-1000 spectrophotometry analysis. Absorbance 331 
of the ELISA reaction product was determined spectrophotometrically using 450 nm 332 
as the primary wave. 333 
 334 
Statistical Analysis and Data Presentation 335 
Statistical analysis was performed with a one-way ANOVA followed by Student-336 
Newman-Keuls’ test, or Student’s t-test. Data were presented as the means ± standard 337 
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deviation (SD), unless otherwise specified. A statistically significant difference was 338 
accepted at P < 0.05. 339 
340 
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RESULTS     341 
BCAAem prevents liver steatosis in rats 342 
Exposure of male Wistar rats to the Lieber DeCarli liquid diet containing 6.2 % EtOH 343 
for 8 weeks resulted in a significant increase of the liver weight, together with fat 344 
accumulation, compared to the pair-fed controls as previously reported (Fig. 1, A and 345 
C) (6, 61). However, experiment #1 demonstrated that dietary supplementation with 346 
BCAAem, although unable to change liver weight per se, prevented both liver growth 347 
and fat accumulation due to alcohol diet, confirming our previous results (Fig. 1A and 348 
C) (21). Conversely, experiment #2 showed that CAA diet, i.e. the Lieber DeCarli 349 
liquid diet containing purified amino acid mixture based on the amino acid profile of 350 
casein, was unable to prevent the EtOH-dependent liver growth (Fig. 1A). Moreover, 351 
the EtOH-fed rats gained less body weight than pair-fed animals, yet in a not 352 
statistically different manner (Fig. 1B), while the body weight of the EtOH-353 
consuming rats treated with BCAAem, unlike with CAA diet, was comparable to that 354 
of pair-fed rats (Fig. 1B). BCAAem and CAA diet were ineffective on body weight 355 
when supplemented alone (Fig. 1B). No statistically significant difference was 356 
evident in food intake among the groups (data not shown) (21). Next, free amino acid 357 
levels were measured in liver tissue. As reported in Table 5, arginine, leucine, and 358 
tryptophan concentrations were reduced by EtOH consumption. While ineffective 359 
when supplemented alone, BCAAem prevented reduction of these three amino acids. 360 
Also, isoleucine, serine, tyrosine, and valine concentrations were lower in liver of 361 
mice exposed to EtOH-containing diet, yet BCAAem supplementation was unable to 362 
prevent their decline. Concentrations of the remaining amino acids were not 363 
statistically different among the groups. Notably, while hepatocytes of the EtOH-364 
consuming rats accumulated many lipid droplets, fat accumulation was prevented by 365 
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the BCAAem supplement (Fig. 1C). This result prompted us to hypothesize that the 366 
specific BCAAem amino acid supplementation could improve the EtOH-induced 367 
mitochondrial dysfunction in hepatocytes.  368 
 369 
BCAAem prevents mitochondrial damage in rat hepatocytes  370 
To this end, electron microscopy analysis was performed on livers from the diverse 371 
groups. Mitochondrial number was significantly reduced in hepatocytes of the EtOH-372 
consuming group relative to pair-fed control rats (Fig. 2 and Table 6). On the other 373 
hand, the mitochondrial mean area was higher, while the mitochondrial area to 374 
cytoplasmic area (Amit/Acyt) ratio was lower in the EtOH-consuming group 375 
compared to the pair-fed group (Fig. 2 and Table 6). Moreover, smooth endoplasmic 376 
reticulum tubules were dilated, and the rough endoplasmic reticulum was 377 
disorganized in hepatocytes of alcohol-consuming animals (Fig. 2). BCAAem 378 
supplementation of EtOH-fed rats markedly increased mitochondria number, in 379 
addition to the mean area and Amit/Acyt ratio (Fig. 2 and Table 6). In animals fed on 380 
EtOH plus BCAAem, smooth and rough endoplasmic reticulum also appeared of 381 
normal size and well organized, comparable to those found in hepatocytes of pair-fed 382 
rats, with abundant glycogen deposits and no macroautophagic vacuoles (data not 383 
shown). BCAAem supplementation alone was unable to change both number and 384 
mean area of mitochondria (Fig. 2 and Table 6). These results were consistent with a 385 
healthy effect of amino acids, suggesting that BCAAem could prevent the EtOH-386 
induced mitochondrial damage by promoting mitochondrial biogenesis in 387 
hepatocytes. 388 
 389 
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BCAAem restores hepatic mitochondrial biogenesis and function impaired by EtOH 390 
consumption 391 
Thus, we evaluated the capacity of BCAAem supplementation to ameliorate impaired 392 
mitochondrial biogenesis and function due to the EtOH consumption. As expected, 393 
the hepatic mRNA levels of proliferator-activated receptor γ coactivator 1α (PGC-394 
1α), nuclear respiratory factor-1 (NRF-1), and mitochondrial DNA transcription 395 
factor A (Tfam) were all lowered by EtOH consumption when compared to pair-fed 396 
control animals. However, these markers were renormalized in livers of rats in which 397 
BCAAem was supplemented together with EtOH (Fig. 3A). BCAAem was ineffective 398 
when supplemented alone. Moreover, in line with electron microscopy results, EtOH 399 
reduced mtDNA amount by 35  1.5 % compared to pair-fed rats, whereas its 400 
consumption with BCAAem increased mtDNA amount by 55  2.6 % and 138  4.0 401 
% compared to pair-fed and EtOH group, respectively (Fig. 3B). In accord to liver 402 
weight results (Fig. 1A), CAA diet was unable to affect mtDNA amount either when 403 
supplemented with EtOH or alone (Fig. 3B). While protein levels of both COX IV 404 
and Cyt c, as well as citrate synthase activity, were reduced in liver of EtOH-405 
consuming rats compared to pair-fed control animals, they were all renormalized in 406 
liver of rats exposed to alcoholic diet supplemented with BCAAem (Fig. 3C and D). 407 
Again, BCAAem supplementation alone did not induce any change in mtDNA, 408 
mitochondrial protein levels, and citrate synthase activity. Collectively these findings 409 
suggest that BCAAem supplementation, by promoting mitochondrial biogenesis and 410 
function, opposes to the hepatic liver mitochondrial damage induced by EtOH 411 
consumption.  412 
 413 
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Since eNOS-dependent NO production was found to promote mitochondrial 414 
biogenesis in different cells, including hepatocytes (30, 57), we analysed eNOS 415 
mRNA and protein levels in livers of both pair-fed controls and EtOH-consuming 416 
rats, supplemented with or without BCAAem. A reduction by 38  2.1 % of eNOS 417 
mRNA level was evident in the EtOH group compared to the pair-fed group, while 418 
the BCAAem supplementation counteracted the effect of EtOH, without an effect per 419 
se (Fig. 4A).  Although EtOH did not decrease eNOS protein level compared to pair-420 
fed control animals, the BCAAem-supplemented alcohol-consuming animals showed 421 
instead a relevant increase of eNOS protein levels (Fig. 4A). Furthermore, differently 422 
from mRNA data, BCAAem supplementation alone induced a significant increase of 423 
eNOS protein. Thus, these results support the hypothesis that eNOS may contribute to 424 
the recovery induced by the amino acid mixture of the EtOH-impaired mitochondrial 425 
biogenesis.  426 
 427 
Given that Sirt1 expression was found to be increased by the eNOS-dependent NO 428 
(57), and Sirt1 in turn deacetylates and activates eNOS and PGC-1 (55), we 429 
investigated this cross-talk in our model. Although we confirmed that EtOH 430 
consumption reduced Sirt1 mRNA levels in liver as previously reported (81, 82), no 431 
changes of Sirt1 protein levels were evident (Fig. 4B). Similarly, BCAAem 432 
supplementation renormalized Sirt1 mRNA without effect on Sirt1 protein level of 433 
EtOH-consuming rats (Fig. 4B). Although it is not uncommon for mRNA and protein 434 
measurements to not be fully concordant (50), we investigated further this point. 435 
Because Sirt1 deacetylase activity is NAD
+
-dependent (35), and the NAD
+
/NADH 436 
ratio is usually decreased in EtOH-consuming animals (31, 34, 78), the effect of 437 
BCAAem supplementation on NAD
+
/NADH levels was studied. As shown in Fig. 438 
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4C, livers of the EtOH-consuming rats displayed a 50 % reduction in NAD+/NADH 439 
ratio, which was however restored by the BCAAem, unlike CAA (data not shown), 440 
supplementation. In line with this, the acetylated form of p53, a well-known target of 441 
Sirt1 (52), was higher in liver of the EtOH-consuming than control rats, indicating 442 
that the deacetylation activity of Sirt1 was reduced in EtOH group (Fig. 4D). 443 
Conversely, acetyl-p53 was decreased by 70 % in liver of rats supplemented with 444 
BCAAem, alone or with EtOH, confirming that the amino acid formula was able to 445 
activate Sirt1 (Fig. 4D). CAA diet was ineffective on Sirt1 activity in all groups (data 446 
not shown). Furthermore, the drop in hepatic Sirt1 activity in EtOH-treated animals 447 
occured in the presence of low eNOS mRNA levels (Fig. 4A) and this, therefore, 448 
strengthens the hypothesis of a cross-talk between Sirt1 and eNOS.  449 
 450 
BCAAem protects from the oxidative damage induced by EtOH  451 
Alcohol metabolism generates reactive oxygen species (ROS), thus leading to 452 
oxidative stress in hepatocytes (4) which is associated with a well-documented 453 
impairment of antioxidant defense system. To verify whether the protection by 454 
BCAAem supplementation against EtOH-induced liver damage also involves 455 
antioxidant effects, we investigated the expression of the anti-ROS enzymes in liver 456 
of EtOH-consuming rats, supplemented or not with the amino acid formula. As 457 
expected, glutathione peroxidase 1 (GPX1), catalase (Cat), and superoxide dismutase 458 
[Cu-Zn], also known as superoxide dismutase 1 (SOD1) mRNA levels were reduced 459 
in EtOH group compared to the pair-fed group (Fig. 5A). However, BCAAem 460 
supplementation increased them by 10-fold (GPX1) and 3-fold (Cat and SOD1), 461 
respectively (Fig. 5A). In addition, the SOD1 protein levels were reduced, although 462 
without a statistical significance, in liver of EtOH rats, while the BCAAem 463 
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supplementation markedly raised Cat and SOD1 (Fig. 5B). These findings suggested 464 
that ROS production was reduced after amino acid supplementation as previously 465 
seen in skeletal muscle of middle-aged mice exposed to BCAAem (23). Accordingly, 466 
while the amount of 8-hydroxy-2’-deoxyguanosine (8-OHdG), a marker of oxidative 467 
DNA damage, was dramatically increased in liver of EtOH-fed rats, this effect was 468 
totally reverted by consumption of BCAAem, which was ineffective when 469 
administered alone (Fig. 5C). 470 
 471 
BCAAem improves mitochondrial function and ROS defense system in EtOH-exposed 472 
HepG2 cells 473 
In order to investigate more deeply the molecular mechanisms involved in the effects 474 
of BCAAem, we extended our findings by using an in vitro model of hepatic EtOH 475 
toxicity. To this end, hepatic HepG2 cells were treated with EtOH, with or without 476 
either BCAAem or CAA mixture. First, we analyzed the mitochondrial biogenesis 477 
markers to confirm the effects of alcohol and amino acids observed in vivo. PGC-1α 478 
and Tfam mRNA levels were unchanged or slightly lower in HepG2 cells exposed to 479 
75 mM EtOH for 9 days, than in untreated control cells (Fig. 6A). However, in line 480 
with in vivo results, 1% BCAAem, unlike CAA mixture, supplementation for 9 days 481 
increased PGC-1 and Tfam mRNA levels with respect to both untreated and EtOH 482 
treated cells (Fig. 6, A and B). Sirt1 mRNA was also increased in HepG2 treated with 483 
BCAAem, but not with CAA mixture, alone or in combination with EtOH (Fig. 6, C 484 
and D). No significant differences were found in Sirt1 protein levels after both EtOH 485 
and BCAAem, as already observed in liver tissue (Fig. 6C). Acetyl-p53 levels were 486 
not significantly different in EtOH-treated compared to untreated HepG2 cells (data 487 
not shown). Accordingly, the NAD
+
/NADH ratio was reduced by only 10 % in 488 
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alcohol-treated compared to untreated cells (Fig. 6E). BCAAem treatment, however, 489 
markedly increased the NAD
+
/NADH ratio in both EtOH-treated and untreated cells 490 
(Fig. 6E). In line with this, BCAAem also lowered acetyl-p53 levels, confirming that 491 
the amino acid mixture was able to activate Sirt1 (data not shown). 492 
 493 
We then investigated the effect of BCAAem treatment on ROS defense system in 494 
cultured cells. SOD1 mRNA and protein levels were reduced by 10 % and 30 %, 495 
respectively, in HepG2 exposed to EtOH compared to untreated cells (Fig. 6F). 496 
However, when HepG2 cells were supplemented with EtOH together with BCAAem, 497 
but not CAA mixture, SOD1 mRNA and protein levels returned to levels similar to 498 
those seen in the untreated cells, while both their protein and mRNA levels increased 499 
by 30 % compared to untreated cells when HepG2 cells were treated with BCAAem 500 
alone (Fig. 6F and data not shown). These in vitro findings, as well as in vivo results, 501 
suggest that the specific BCAAem formula is able to counteract the toxic effects of 502 
EtOH on mitochondrial function, and to reduce the EtOH-induced oxidative stress by 503 
specifically acting on hepatic tissue and in a cell-autonomous manner,  504 
 505 
BCAAem improves fat oxidation in EtOH-exposed HepG2 cells 506 
Since it is well known that oxidative stress and mitochondrial dysfunction lead to fat 507 
accumulation in hepatocytes, we studied the efficacy of amino acid supplementation 508 
to counteract the EtOH-dependent impairment of fat β-oxidation of fatty acids. 509 
Expression of carnitine palmitoyltransferase 1 (CPT1), also known as carnitine 510 
acylpalmitoyltransferase 1, the key enzyme in the regulation of -oxidation of long-511 
chain fatty acids, was in fact reduced by alcohol as compared to untreated HepG2 512 
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(Fig. 7A). On the contrary, BCAAem up-regulated CPT1 mRNA when administered 513 
alone or with EtOH (Fig. 7A).  514 
 515 
Moreover, to assess the possible effect of BCAAem supplementation on the EtOH-516 
induced excessive fat storage, the intracellular lipid accumulation was analyzed by 517 
Oil Red O staining in HepG2 cells treated with 100 nM EtOH and 1 % BCAAem. 518 
Following 48 h treatment, the lipid content was significantly increased when HepG2 519 
cells were exposed to EtOH, whereas it was reduced when the cells were exposed to 520 
BCAAem compared to untreated cells (Fig. 7B). In addition, BCAAem 521 
supplementation was able to renormalize the lipid content in the EtOH-treated HepG2 522 
cells (Fig. 7B). 523 
 524 
EtOH and BCAAem control multiple signaling pathways in HepG2 cells 525 
Given that BCAAem was found to promote eNOS-dependent NO production, and NO 526 
is also known to control -oxidation in muscle (23, 44), we analyzed the expression 527 
of eNOS and its activity in HepG2 treated with EtOH, with or without BCAAem. A 528 
slight decrease of eNOS mRNA was observed in cells treated with EtOH. BCAAem, 529 
however, increased eNOS mRNA, both supplemented alone or together with EtOH, 530 
compared to the untreated cells (Fig. 8A) Yet, eNOS activity, measured as Ser1177-531 
eNOS phosphorylation (19), was markedly reduced in EtOH treated cells (Fig. 8A). 532 
Although ineffective on eNOS activity when supplemented alone, BCAAem 533 
completely restored the EtOH-induced decrease of eNOS-phosphorylation (Fig. 8B). 534 
To strengthen further the role of eNOS on mitochondrial protection by BCAAem 535 
supplementation, HepG2 cells were transfected with small interference RNA (siRNA) 536 
against eNOS or nontargeting siRNA as a negative control. We verified that eNOS 537 
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siRNA reduced eNOS protein levels by 70 % (Fig. 8C). While HepG2 treated with 538 
EtOH showed decreased PGC-1 and COXIV protein levels, and BCAAem 539 
supplementation promoted a statistically significant recovery of both proteins, eNOS 540 
knockdown blocked the BCAAem effects in the presence or not of EtOH (Fig. 8C). 541 
Importantly, the eNOS silencing per se did not modify PGC-1 and COXIV levels. 542 
Thus, our present results suggest that the effects of BCAAem on mitochondrial 543 
parameters are at least in part mediated by eNOS in hepatic cells. We had previously 544 
demonstrated that the eNOS-derived NO promotes mitochondrial biogenesis in 545 
various cell types through guanosine 3’,5’-monophosphate (cyclic GMP, or cGMP) 546 
(57). Thus, we examined the effect of the selective guanylate cyclase inhibitor 1H-547 
[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one (ODQ). Co-incubation of BCAAem with 548 
ODQ (5 M) for 2 days reversed the positive effect of amino acid supplementation on 549 
reduction of PGC-1 and COX IV protein induced by EtOH, whereas ODQ alone 550 
had no effect (Fig. 8D). Thus, the eNOS-produced NO through activation of cGMP-551 
dependent signal transduction pathway may promote the healthy effects of BCAAem 552 
on mitochondria of hepatic cells. 553 
 554 
Protein kinase B (PKB), also known as Akt, is a serine/threonine-protein kinase that 555 
plays a key role in multiple cellular processes, such as glucose metabolism, cell cycle, 556 
and angiogenesis, in addition to regulate, among others, eNOS activity (53). On these 557 
basis, we investigated Akt function, measured  as phosphorylation in Ser473, in 558 
untreated or ethanol-treated HepG2 cells, with or without BCAAem. We observed a 559 
marked decrease of p-Akt normalized to total Akt in HepG2 cells treated with EtOH, 560 
which was completely restored by BCAAem (Fig. 8B). BCAAem increased Akt 561 
phosphorylation also when supplemented alone compared to untreated cells (Fig. 8B). 562 
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Since eNOS-dependent NO production is known to regulate mTOR system in 563 
different cell types (7, 23, 63, 83), we also investigated the mTOR pathway in our 564 
experimental model. Phosphorylation levels of ribosomal protein p70S6 kinase, a 565 
major downstream target of mTOR complex 1 (TORC1), was measured in HepG2 566 
cells by immunoblot analysis. We observed a 40 % decrease of phospho-p70S6 567 
kinase, normalized to total p70S6 kinase, after EtOH exposure compared to untreated 568 
cells, which was completely rescued by BCAAem supplementation (Fig. 8B, D and 569 
E). This effect was antagonized by rapamycin, a macrolide compound that inhibits 570 
mTORC1 signaling (Fig. 8E), thus confirming the direct involvement of mTORC1 in 571 
the mechanism of action of BCAAem. Notably, the rescue of defective mitochondrial 572 
biogenesis markers by BCAAem was consistently antagonized by rapamycin in 573 
HepG2 exposed to EtOH (Fig. 8F). Moreover, ODQ fully antagonized the effects of 574 
BCAAem on phospho-p70S6 kinase in hepatic cells treated or not with EtOH (Fig. 575 
8D), supporting the role of NO-dependent cGMP on mTORC1 activity. Thus, our 576 
results suggest that the healthy effects of BCAAem on mitochondrial function in the 577 
EtOH-treated HepG2 cells could be due to a Sirt1-eNOS-Akt-mTORC1 signaling 578 
pathway.   579 
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DISCUSSION   580 
In this paper, we showed that dietary supplementation of BCAAem protected rats 581 
against alcoholic fatty liver and mitochondrial dysfunction, by reversing most of the 582 
EtOH-induced metabolic impairments. Several studies have demonstrated that 583 
chronic alcohol consumption leads to morphological and functional changes of 584 
mitochondria in different organs, including liver (37), in both animals and humans 585 
(62). Mitochondrial enlargement and swelling, with uncommon shapes and giant 586 
mitochondria (38, 39), characterized by high matrix density (33, 42, 48), 587 
mitochondrial cristae shortening and disorganization, decreased mitochondrial 588 
number, or absence of matrix granules and intramitochondrial crystalline inclusions 589 
have been described in hepatocytes of alcoholics. Consequently, these changes 590 
affect mitochondrial functions, leading to reduced respiratory rates and ATP 591 
synthesis (2), in addition to increased ROS production (69). Thus, mitochondrial 592 
dysfunction contributes largely to initiation and progression of the alcohol-induced 593 
liver damage, also because the liver deficit in maintaining energy production 594 
precedes inadequate adaptive organ repairing mechanisms (5).  595 
 596 
Our findings that dietary BCAAem supplementation was able to prevent the decline 597 
in mitochondrial biogenesis markers (i.e., PGC-1, NRF-1, and Tfam) and mtDNA, 598 
as well as respiratory-chain proteins COX IV and Cyt c, and mitochondrial citrate 599 
synthase activity, that occurs in the liver of EtOH-consuming rats indicate, therefore, 600 
that the mitochondrial stimulating activity of BCAAem mixture impinges on its 601 
protective effect against ALD. Restoring mitochondrial function by BCAAem 602 
improves the metabolic derangement caused by EtOH ingestion. Reduced fat 603 
accumulation was in fact observed in livers of EtOH-fed rats supplemented with 604 
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BCAAem. Accordingly, BCAAem was also able to upregulate CPT1 expression, the 605 
key enzyme in mitochondrial β-oxidation of fatty acids, whose expression was 606 
decreased in EtOH-fed animals. Impaired fatty acid oxidation in alcohol-consuming 607 
rats, and its recovery by BCAAem supplementation, could therefore underlie the 608 
mechanism involved in the EtOH damage and in the protective effect of the amino 609 
acid supplement, respectively. Although the stimulatory effect of BCAAem 610 
supplement on CPT1 expression might be linked to the ketogenic potential of 611 
leucine and lysine (59), our experimental conditions seem to exclude this hypothesis 612 
since ketogenesis is strictly linked to a shortage of carbohydrate, while HepG2 cells 613 
were maintained in 2 g/L glucose culture medium. Moreover, the increased 614 
expression of SOD1, GPX1, and catalase observed in BCAAem-fed rats also 615 
indicates a protective action of the amino acid supplement against the EtOH-induced 616 
oxidative stress (45), which was after all confirmed by the ability of BCAAem to 617 
reduce 8-OHdG amount in liver DNA of the alcoholic animals. 618 
 619 
Hepatic ethanol metabolism occurs mainly via oxidation by means of alcohol 620 
dehydrogenase (ADH) and aldehyde dehydrogenase (ALDH). Both ADH and 621 
ALDH use NAD
+
 as an enzymatic cofactor, which is reduced to NADH. 622 
Consequently, during ethanol oxidation the NAD
+
/NADH ratio is significantly 623 
decreased, altering the cellular redox state and triggering several adverse events 624 
(60). These include inhibition of tricarboxylic acid (TCA) cycle and reduction of 625 
fatty acid oxidation, which may lead to hepatic steatosis (75). Moreover, changes of 626 
NAD
+
/NADH ratio may be also linked to a decreased Sirt1 deacetylase activity, 627 
being Sirt1 a NAD
+
-dependent enzyme whose activity improves mitochondrial 628 
function (46). Accordingly, the liver NAD
+
/NADH ratio was decreased in rats after 629 
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EtOH consumption and, most importantly, dietary supplementation with BCAAem 630 
restored this ratio with increase of Sirt1 activity.  631 
 
Reduction of Sirt1 and PGC-1, that causes mitochondrial dysfunction in liver of 632 
the alcohol-consuming animals (49), was accompanied by reduced expression and 633 
function of eNOS. This seems to be relevant, because we have previously 634 
demonstrated that the eNOS-dependent NO production promotes both Sirt1 635 
expression in different tissues, including liver (58), and mTOR activity in skeletal 636 
and cardiac muscle cells (23). Moreover, BCAAem was found to activate both 637 
eNOS and mTOR signaling pathways in a feed-forward manner in muscle (23). 638 
Notably, our present findings highlight that the amino acid supplementation, 639 
although unable to change the free amino acid levels in liver when supplemented 640 
alone, normalized the liver concentrations of free arginine, leucine, and tryptophan 641 
that were reduced by alcohol consumption. Arginine, a substrate of eNOS, produces 642 
NO for signaling purposes and citrulline as a byproduct. It is a conditionally 643 
essential amino acid in both humans and rodents, as it may be required depending on 644 
the health status or life cycle of the individual (8). Arginine has been proposed as 645 
therapeutic supplement in patients with MELAS (mitochondrial 646 
encephalomyopathy, lactic acidosis, and stroke-like episodes) syndrome, which has 647 
lower concentrations of NO metabolites (nitrite and nitrate) during stroke-like 648 
episodes (40). A few studies investigated the efficacy of high doses of arginine for 649 
attenuation of ethanol withdrawal signs or in hepatic encephalopathy and 650 
hyperammonemia (1, 67, 74). Also, leucine, an essential branched-chain amino acid 651 
whose breakdown products are acetyl-CoA and acetoacetate, is the most important 652 
ketogenic amino acid in humans (8). Great advances are currently in progress toward 653 
Downloaded from www.physiology.org/journal/ajpgi by ${individualUser.givenNames} ${individualUser.surname} (159.149.103.006) on February 20, 2018.
Copyright © 2018 American Physiological Society. All rights reserved.
 30 
a molecular definition of leucine-dependent mTORC1 activation to coordinate 654 
eukaryotic cell growth and metabolism with environmental inputs, including 655 
nutrients and growth factors (79). In particular, research has established a central 656 
role for mTOR in regulating numerous essential cell processes – from protein 657 
synthesis to autophagy – and mTOR signaling dysfunction is implicated in cancer 658 
and diabetes development as well as in aging (70). Leucine supplementation has 659 
beneficial effects in malnourished elderly people with skeletal muscle dysfunction 660 
(i.e., sarcopenia) and in other disorders. Moreover, leucine promotes mitochondrial 661 
biogenesis, in addition to increase protein synthesis (26). Malnutrition and its major 662 
component sarcopenia are known to be primarily responsible for the adverse clinical 663 
consequences in patients with liver disease (25). EtOH and its metabolites act on 664 
skeletal muscle, and the consequences of liver disease result in disturbed 665 
proteostasis (i.e., protein homeostasis) and sarcopenia. Leucine supplementation and 666 
mitochondrial biogenesis promoting agents are currently in active evaluation to 667 
prevent and reverse sarcopenia in patients with ALD and cirrhosis (25). Finally, 668 
tryptophan catabolism in mammals – whose first step is mediated by tryptophan 669 
dioxygenase, an enzyme mainly confined to the liver - is known to be implicated in 670 
synthesis of the nicotinamide ring of NAD
+
 (8). A greater liver tryptophan 671 
availability would therefore lead to an increase in activity of hepatic tryptophan 672 
dioxygenase and, thus, NAD
+
 synthesis. This is consistent with our present results 673 
on the BCAAem efficacy to normalize the reduced NAD
+
/NADH ratio and Sirt1 674 
activity in liver of EtOH-consuming rats. Plasma levels of tryptophan are reduced in 675 
patients with alcoholic liver cirrhosis (65), and clinical studies have confirmed that 676 
tryptophan protects liver from non-alcoholic fatty liver disease (NAFLD) and 677 
preserves the organ during partial resection surgery (16). Thus, our results on free 678 
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amino acid levels in liver suggest that a selective amino acid mixture may influence 679 
healthily metabolism of specific amino acids affected by the EtOH assumption.   680 
 681 
Because numerous studies have demonstrated that the alcohol effects on liver are 682 
dependent on complex systemic regulatory molecules, including for example sex 683 
hormones (72), the mechanistic relationships among metabolic sensors and signaling 684 
systems were investigated in cultured HepG2 cells. In particular, eNOS knockdown 685 
by means of selective eNOS siRNA in HepG2 cells significantly blocked the 686 
beneficial effects of amino acid supplementation on mitochondrial dysfunction 687 
induced by EtOH. This suggested the relevance of eNOS-dependent NO in 688 
mediating these effects. In fact, ODQ - the selective inhibitor of NO-dependent 689 
guanylate cyclase - blocked the BCAAem action on mitochondrial markers, 690 
strengthening that the NO protective activity is a cGMP-dependent process. In line 691 
with this, the levels of phospho-Akt and phospho-p70S6K showed the same 692 
regulation, with reduced levels after EtOH-treatment and recovered levels after 693 
EtOH plus BCAAem treatment. Exposure of HepG2 cells to BCAAem also 694 
counteracted the mitochondrial dysfunction induced by EtOH, and this protective 695 
effect was blocked by rapamycin treatment, suggesting the involvement of 696 
mTORC1 signaling in the mitochondrial protective effect of BCAAem. Recent 697 
studies have identified Akt, mTORC1, and p70S6K as positive mediators in 698 
promoting de novo lipogenesis (70). All of these kinases converge on and activate 699 
sterol regulatory element-binding protein 1c (SREBP1c), the master transcription 700 
factor coordinating the expression of enzymes involved in lipid synthesis (71). 701 
Experiments in genetically modified livers highlight the central role of Akt in 702 
promoting lipogenesis. Kenerson et al. (36) have recently investigated the molecular 703 
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mechanisms involved in NAFLD induced in mice by 8-week consumption of an 704 
high-fat diet. By using in vivo single and combined genetic deletions (Tsc1, S6K1, 705 
and Pten null-mutant mice), they reported that mTORC1 activation promoted 706 
protection of liver from the HFD-induced lipid accumulation through p70S6K, 707 
independent of Akt suppression (36). Their results suggest that a number of 708 
“compensatory” mechanisms may provide protection against steatosis when Akt and 709 
mTORC1 are co-activated. Consistently, our present results show that the dietary 710 
activation of both mTORC1 and Akt seem to be related to the protective effects of 711 
amino acid supplementation in the alcohol-induced fatty liver. Compensatory 712 
expression of CPT1 and fat oxidation have been indeed described in our as in 713 
Kenerson et al.’s paper (36). 714 
 715 
Finally, casein-amino acids, differently of BCAAem, were unable to both prevent 716 
liver growth and ameliorate the EtOH-impaired mitochondrial biogenesis under in 717 
vivo and in vitro experimental conditions, suggesting that only specific amino acid 718 
formulas may have benefic effects on selective liver diseases. Nutritional 719 
supplements with BCAAs have been assessed as a treatment option for cirrhosis and 720 
hepatic encephalopathy (in which the proportion of patients with alcoholic liver 721 
disease is usually very high), and multiple systematic reviews have analyzed 722 
randomized controlled trials on BCAAs compared with no intervention, placebo, or 723 
other (3, 41). A systematic review with meta-analyses of randomized controlled 724 
trials has found that oral BCAA supplements improved the manifestations of 725 
recurrent hepatic encephalopathy in patients with cirrhosis, without effects on 726 
mortality, nutrition, or adverse events (29). Clinical trials testing BCAA 727 
supplementation in humans with various other liver diseases have been published 728 
Downloaded from www.physiology.org/journal/ajpgi by ${individualUser.givenNames} ${individualUser.surname} (159.149.103.006) on February 20, 2018.
Copyright © 2018 American Physiological Society. All rights reserved.
 33 
with mixed, not conclusive results. Mixed results can be due to the complex 729 
mechanisms involved and the clinical differences between patients with acute or 730 
recurrent disorders. Moreover, the mode of administration, i.e. oral and parenteral 731 
administration, inclusion criteria, additional patient and intervention characteristics 732 
may influence the intervention benefits. Our present in vivo and in vitro results may 733 
suggest that patients with diverse liver diseases need specific amino acid formulas. 734 
Moreover, mitochondrial dysfunction may be considered as a target of beneficial 735 
effect of BCAAem, strengthening the hypothesis that focusing on mitochondrial 736 
function to screen molecules and/or nutrients for liver disease therapy is a promising 737 
strategy. Similarly, the Sirt1-eNOS-Akt-mTORC1 signaling pathway may be 738 
considered a therapeutic target of liver diseases. This result suggests that NO donors 739 
and/or Sirt1 agonists, in addition to mTOR modulators, might prevent the EtOH-740 
induced hepatic steatosis. In summary, our findings therefore support the hypothesis 741 
that only some specific amino acid mixtures are able to protect liver against alcohol 742 
damage acting on mitochondria, possibly through a Sirt1-eNOS-Akt-mTORC1 743 
cross-talk signaling pathway. Thus, if that were true also in humans the dietary 744 
supplementation of the present or improved formula might represent a promising 745 
strategy for prevention and treatment of alcoholic liver disease.  746 
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Figure Legends  1040 
 1041 
Figure 1. BCAAem supplementation normalizes liver and body weight of EtOH-1042 
consuming rats. (A) Liver and (B) body weight of pair-fed rats (pair-fed CTRL, n = 1043 
6), consuming a control liquid diet in which EtOH was replaced by isocaloric maltose 1044 
dextran, and rats fed with a Lieber-DeCarli liquid diet containing EtOH or 1045 
BCAAem/CAAem or EtOH plus BCAAem/CAAem (n = 6-7). Data in (A) and (B) 1046 
represent mean ± SD (
*
P < 0.05 vs CTRL rats). (C) Hematoxylin and eosin liver 1047 
staining of CTRL, BCAAem, EtOH, and EtOH plus BCAAem fed rats. Scale bar, 100 1048 
µm. Analyses were performed in two animals per group. Representative staining 1049 
images from at least three independent experiments are reported. 1050 
 1051 
Figure 2. Electron miscrocopy analysis shows that BCAAem supplementation 1052 
ameliorated the liver mitochondrial damage induced by alcohol. The EtOH-1053 
consuming rats had fewer mitochondria than pair-fed animals, whereas the BCAAem 1054 
supplementation renormalized their density. N, nucleus; scale bar, 0.1 µm 1055 
(magnification x5,200). Analyses were performed in two animals per group. 1056 
Representative images from at least three independent experiments are reported. 1057 
 1058 
Figure 3. Mitochondrial biogenesis and function markers are decreased in liver of 1059 
EtOH-consuming rats, whereas supplementation with BCAAem unlike CAA diet 1060 
restores them to control levels. (A) PGC1-,  NRF-1, and Tfam mRNA levels were 1061 
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analyzed by means of quantitative RT-PCR. Relative expression values of the CTRL 1062 
rats were taken as 1.0 (B) mtDNA amount was analyzed by means of quantitative 1063 
RT-PCR. Relative units were expressed in comparison to those of the CTRL rats 1064 
taken as 1.0.  (C) COX IV and Cyt c protein levels were detected by immunoblot 1065 
analysis.  The relative values were measured by densitometric analysis relative to β-1066 
actin levels. Values in CTRL rats were taken as 1.0 (D) Citrate synthase activity of 1067 
liver. The values were normalized to protein content (n = 5 experiments). All data 1068 
represent mean ± SD. 
*
P < 0.05 vs. CTRL; 
#
P < 0.05 vs. EtOH-consuming rats.  1069 
 1070 
Figure 4. eNOS and Sirt1 expression in liver, in addition to NAD
+
/NADH ratio and 1071 
Sirt1 activity, are reduced by EtOH consumption, while BCAAem supplementation 1072 
renormalizes them to control levels. (A) eNOS and (B) Sirt1 mRNA levels were 1073 
analyzed by means of quantitative RT-PCR and Western blot, respectively. Relative 1074 
expression values in CTRL rats were taken as 1.0. (C) NAD
+ 
to NADH ratio was 1075 
measured by means of a NAD
+
/NADH quantification kit. The values were 1076 
normalized to protein content. (D) Acetyl-p53 protein levels were measured by 1077 
immunoblot analysis, and the relative values detected by densitometric analysis 1078 
relative to the total p53. Values of CTRL were taken as 1.0 (n = 5 experiments). All 1079 
data represent mean ± SD. 
*
P < 0.05 vs. CTRL; 
#
P < 0.05 vs. EtOH-consuming rats.  1080 
 1081 
Figure 5. EtOH consumption induces oxidative damage in liver, while BCAAem 1082 
supplementation coordinated an antioxidant effect. (A) Glutathione peroxidase 1 1083 
(GPX1), catalase (Cat), and superoxide dismutase 1 (SOD1) mRNA levels were 1084 
analyzed by means of quantitative RT-PCR, and the relative expression values of 1085 
untreated rats (CTRL) were taken as 1.0 (n = 3 experiments). (B) Cat and SOD1 1086 
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protein levels were detected by immunoblot analysis. The relative values were 1087 
detected by densitometric analysis, relative to β-actin levels; values of CTRL were 1088 
taken as 1.0. (C) Total DNA oxidative damage measured as 8-OHdG production in 1089 
liver of EtOH and BCAAem-treated mice (n = 3 experiments). 
*
P < 0.05 vs. CTRL 1090 
rats; 
#
P < 0.05 vs. EtOH-consuming rats. 1091 
 1092 
Figure 6. Mitochondrial biogenesis markers, in addition to Sirt1 expression and 1093 
NAD
+
/NADH ratio, are decreased in HepG2 cells exposed to EtOH, whereas 1094 
supplementation with BCAAem restores them to control levels. (A, B, C, and D) 1095 
PGC1-, Tfam, and Sirt1 mRNA levels were analyzed by means of quantitative RT-1096 
PCR. Relative expression values in the untreated cells were taken as 1.0. Sirt1 protein 1097 
level was detected by immunoblot analysis (C, right).  The relative values were 1098 
detected by densitometric analysis relative to β-actin. The untreated cell values were 1099 
taken as 1.0. (E) NAD
+ 
to NADH ratio in HepG2 cells was measured by means of a 1100 
NAD
+
/NADH quantification kit. The values were normalized to protein content. (F) 1101 
SOD1 mRNA levels were analyzed in HepG2 cells by means of quantitative RT-1102 
PCR. Relative expression values of the untreated cells were taken as 1.0. SOD1 1103 
protein level was detected by immunoblot analysis.  The relative values were detected 1104 
by densitometric analysis, relative to β-actin levels. Values of untreated cells were 1105 
taken as 1.0. All data represent mean ± SD (n = 5 experiments). 
*
P < 0.05 vs. 1106 
untreated cells; 
#
P < 0.05 vs. EtOH-treated cells. 1107 
 1108 
Figure 7. BCAAem reduces fat accumulation in HepG2 cells. (A) Carnitine 1109 
palmitoyltransferase I (CPT1) mRNA levels were analyzed by means of quantitative 1110 
RT-PCR. Relative expression values of the untreated cells were taken as 1.0. (B) 1111 
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Lipid droplets were measured by Oil Red O staining, then dissolved in isopropanol 1112 
and quantified by reading the absorbance at 510 nm wavelength. All data represented 1113 
mean ± SD (n = 5 experiments). 
*
P < 0.05 vs. untreated cells; 
#
P < 0.05 vs. EtOH-1114 
treated cells.  1115 
 1116 
Figure 8. eNOS and mTORC1 signaling are involved in the protective effect of 1117 
BCAAem supplementation in HepG2 cells. (A) eNOS mRNA was analyzed by means 1118 
of quantitative RT-PCR. Relative expression value of untreated cells was taken as 1119 
1.0. (B) Phosphorylation of eNOS, Akt, and p70S6 kinase protein was detected by 1120 
immunoblot analysis. The relative values were detected by densitometric analysis and 1121 
normalized to total eNOS, Akt, and p70S6 kinase proteins. (C) eNOS, PGC-1, and 1122 
COX-IV protein levels were measured by immunoblot analysis in HepG2 cells 1123 
transfected with either siRNA against eNOS or nontargeting siRNA, and treated with 1124 
EtOH or BCAAem alone, or with EtOH in combination with BCAAem. (D) PGC-1 1125 
and COX-IV protein expression, and phosphorylation of p70S6 kinase were detected 1126 
by immunoblot analysis in HepG2, treated with EtOH or BCAAem alone, or with 1127 
EtOH plus BCAAem coincubated with or without 5 M ODQ for 2 days. (E) 1128 
Phosphorylation of p70S6 kinase and (F) Cyt c and COX-IV protein levels were 1129 
detected by immunoblot analysis in HepG2 with or without 100 nM rapamycin. 1130 
Values of untreated or vehicle-treated cells were taken as 1.0. Representative 1131 
immunoblots of five reproducible ones are shown. All data represent mean ± SD (n = 1132 
5 experiments). 
*
P < 0.05 and 
**
P < 0.01 vs. untreated or vehicle-treated cells; 
#
P < 1133 
0.05 vs. EtOH-treated cells; 
†
P < 0.01 vs. BCAAem plus EtOH-treated cells. 1134 
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Figure 1 
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Figure 2 
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Figure 3 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
Downloaded from www.physiology.org/journal/ajpgi by ${individualUser.givenNames} ${individualUser.surname} (159.149.103.006) on February 20, 2018.
Copyright © 2018 American Physiological Society. All rights reserved.
 4 
 
Figure 4 
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Figure 5 
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Figure 6 
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 Table 1. Composition of diets used in the present work   
 
Diet ingredients 
Composition, grams/L 
CTRL EtOH CAA BCAAem EtOH+ 
CAA 
EtOH+ 
BCAAem 
Casein 41.4 41.4 41.4 41.4 41.4 41.4 
L-Cystein 0.5 0.5 0.5 0.5 0.5 0.5 
DL-Methionine 0.3 0.3 0.3 0.3 0.3 0.3 
Corn Oil 8.5 8.5 8.5 8.5 8.5 8.5 
Olive Oil 28.4 28.4 28.4 28.4 28.4 28.4 
Safflower Oil 2.7 2.7 2.7 2.7 2.7 2.7 
Maltose Dextrin 115.2 25.6 115.2 115.2 115.2 25.6 
Cellulose 10 10 10 10 10 10 
Mineral Mix 8.75 8.75 8.75 8.75 8.75 8.75 
Vitamin Mix 2.5 2.5 2.5 2.5 2.5 2.5 
Choline Bitartrate 0.53 0.53 0.53 0.53 0.53 0.53 
Xanthan Gum 3 3 3 3 3 3 
Ethanol - 6.2* - - 6.2* 6.2* 
Histidine - - 0.26 0.27 0.26 0.27 
Isoleucine - - 0.43 1.56 0.43 1.56 
Leucine - - 0.9 3.05 0.9 3.05 
Lysine - - 0.75 1.32 0.75 1.32 
Methionine+cysteine - - 0.36 0.54 0.36 0.54 
Phenylalanine - - 0.48 0.16 0.48 0.16 
Threonine - - 0.41 1.08 0.41 1.08 
Tryptophan - - 0.12 0.02 0.12 0.02 
Valine 
Alanine 
Arginine 
Aspartic acid 
Glutamic acid 
Glycine 
Proline 
Serine 
Tyrosine 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
0.53 
0.29 
0.34 
0.69 
2.17 
0.17 
1.01 
0.57 
0.52 
1.96 
- 
- 
- 
- 
- 
- 
- 
- 
0.53 
0.29 
0.34 
0.69 
2.17 
0.17 
1.01 
0.57 
0.52 
1.96 
- 
- 
- 
- 
- 
- 
- 
- 
 
*Ethanol is expressed as % (vol/vol). The different diets are isocaloric. 
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Table 2. Ion transitions, instrument settings and weighted regression for 
amino acid detection 
 
Table reports the mass spectrometry parameters as determined by 
infusion of each amino acid. In each standard mixture, name, precursor 
(m/z), product (m/z), DP, declustering potential (V), CE, collision 
energy (V) and weighted regression are indicated for each amino acid. 
 
MIX_1 
     
AA 
Precursor 
(m/z) 
Product 
(m/z) DP  CE 
Weighted 
regression 
Serine 106,051 60,044 30 15 1/x 
Asparagine 133,061 74,024 30 15 1/x
2
 
Tyrosine 182,082 165,053 30 15 1/x
2
 
Threonine 120,066 56,049 30 15 1/x 
      
      MIX_2 
     
AA 
Precursor 
(m/z) 
Product 
(m/z) DP  CE 
Weighted 
regression 
Glycine 76,040 30,033 40 15 1/x 
Alanine 90,056 44,053 40 15 1/x 
Leucine 132,103 86,096 40 15 1/x 
Isoleucine 132,103 69,072 40 15 1/x 
Valine 118,087 72,081 40 15 1/x
2
 
Proline 116,071 70,065 40 15 1/x 
Histidine 156,077 109,830 40 15 1/x 
Methionine 150,059 104,053 40 15 1/x 
Aspartic acid 134,045 74,023 40 15 1/x 
Glutamine 147,077 84,015 40 15 1/x 
Phenylalanine 166,087 119,964 40 15 1/x 
      
      MIX_3 
     
AA 
Precursor 
(m/z) 
Product 
(m/z) DP  CE 
Weighted 
regression 
Glutamic acid 148,061 102,056 80 18 1/x
2
 
Lysine 147,113 84,093 80 18 1/x 
Arginine 175,12 116,072 80 18 1/x 
Tryptophan 205,098 188,07 80 18 1/x 
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 Table 3. Rat primers for quantitative RT-PCR 
 
Gene Primer Sequences PCR Product (bp) Ta (°C) 
Tfam 
Sense 5’- CAGAGTTGTCATTGGGATTGGG -3’ 
140 60 
Antisense 5’- GCATTCAGTGGGCAGAAGTC -3’ 
NRF1 
Sense 5’- TATCCGAAAGAGACAGCAGACAC -3’ 
130 60 
Antisense 5’- CTTAAAGACAGGGTTGGGTTTGG -3’ 
PGC1α 
Sense 5’- CCACTACAGACACCGCACACATC -3’ 
141 60 
Antisense 5’- TCTCTGCGGTATTCGTCCCTCTT -3’ 
eNOS 
Sense 5’- CACAGGCATCACCAGGAAGAAG -3’ 
98 60 
Antisense 5’- CCTTCACACGCTTCGCCATC -3’ 
TBP 
Sense 5’- GCAGCCTCAGTACAGCAATC -3’ 
167 60 
Antisense 5’- TGGTGTGGCAGGAGTGATAG 3’ 
ND1 
Sense 5’- GGACCTAAGCCCAATAACGA -3’ 
348 58 
Antisense 5’- GCTTCATTGGCTACACCTTG -3’ 
 
GPX1 
Sense 
Antisense 
5’ – CAGGAGAATGGCAAGAATGAAGAG -3’ 
5’ – ACTGGGTGCTGGCAAGGC -3’ 
145 60 
 
Cat 
Sense 
Antisense 
5’- CATCGGCACATGAATGGC -3’ 
5’ – ACCTTGGTCAGGTCAAATGG -3’ 
281 60 
 
SOD1 
Sense 
Antisense 
5’- TGAAGAGAGGCATGTTGGAG -3’ 
5’ – CCACCTTTGCCCAAGTCATC -3’ 
164 58 
βglobin 
Sense 5’- CTTCTGGCTATGTTTCCCTT -3’ 
237 58 
Antisense 5’- GTTCTCAGGATCCACATG -3’ 
 
Ta, temperature of annealing 
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 Table 4. Human primers for quantitative RT-PCR 
Gene Primer Sequences PCR Product (bp) Ta (°C) 
Tfam 
Sense 5’- AGATTGGGGTCGGGTCAC -3’ 
184 60 
Antisense 5’- GACAACTTGCCAAGACAGATG -3’ 
NRF1 
Sense 5’- ACTCGTGTGGGACAGCAAGC -3’ 
200 60 
Antisense 5’- ATGGTGAGAGGCGGCAGTTC -3’ 
PGC1α 
Sense 5’- GACCCCAGAGTCACCAAATGAC -3’ 
132 60 
Antisense 5’- TTGGTTGGCTTTATGAGGAGGA -3’ 
eNOS 
Sense 5’- TGACCCTCACCGCTACAACATC -3’ 
103 60 
Antisense 5’- TGATTTCCACTGCTGCCTTGTCT -3’ 
CPT1 
Sense 5’- GGAGAGGAGACAGACACC ATCCA -3’ 
243 60 
Antisense 5’- CAAAATAGGCCTGACGACACCTG 3’ 
ACOX1 
Sense 5’- TGGTGAAGAAGATGAGGGAGT -3’ 
126 60 
Antisense 5’- AGCAAGGTGGGCAGGAAC -3’ 
SOD1 
Sense 5’- GAGACGGGGTGCTGGTTTGC -3’ 
82 60 
Antisense 5’- ACGCCGAGGTCCTGGTTCC -3’ 
Sirt1 
Sense 5’- GGGAGGCGGAGGCAGAGG -3’ 
154 60 
Antisense 5’- TCGTCGTCGTCGTCTTCGTC -3’ 
TBP 
Sense 5’- AGGCACCACAGCTCTTCCAC -3’ 
130 60 
Antisense 5’- CCCAGAACTCTCCGAAGCTG -3’ 
 
Ta, temperature of annealing. 
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 Table 5. Amino acid concentrations measured using chromatography in liver 
 
 
Values are reported as means ± SD (pmol/mg of tissue), n = 4 animals/group; *P value < 0.05 shows 
difference vs. CTRL group, 
#
P value < 0.05 shows difference vs. EtOH group. 
 
 
CTRL BCAAem EtOH EtOH+BCAAem 
Alanine 670.1 ± 65.7 832.0 ± 25.0 691.2 ± 128.0 679.0 ± 110.0 
Arginine 6.6 ± 0.7 4.3 ± 0.8 2.46 ± 0.5* 4.3 ± 0.7# 
Asparagine 8.9 ± 2.4 7.9 ± 2.7 8.1 ± 2.1 6.9 ± 2.8 
Glycine 409.8 ± 78.2 479.8 ± 32.0 424.1 ± 52.0 440.7 ± 67.2 
Glutamic acid 5232.0 ± 430.0 5394.0 ± 438.0 5970.5 ± 832.0 4717.70 ± 850 
Histidine 527.9·10
3 ± 80.3·103 606.8·103 ± 10.8·103 461.1·103 ± 44.6 ·103 406.0x103 ± 19.3·103 
Isoleucine 141.9 ± 29.7 144.4 ± 4.5 92.9 ± 16.6* 93.2 ± 17.9* 
Leucine 195.0 ± 56.4 189.1 ± 81.9 110.2 ± 18.8 * 188.9 ± 92.4# 
Lysine 72.2 ± 16.8 90.5 ± 19.7 62.3 ± 9.6 53.3 ± 6.4 
Methionine 12.9 ± 5.5 17.9 ± 5.3 11.9 ± 3.9 17.8 ± 4.7 
Phenylalanine 32.0 ± 13.2 36.4 ± 4.8 27.7 ± 10.2 28.8 ± 5.2 
Proline 33.7 ± 5.2 33.5 ± 1.3 27.2 ± 8.7 24.6 ± 4.2 
Serine 348.7 ± 33.9 362.4 ± 9.9 220. 7 ± 58.4* 215.4 ± 43.0* 
Threonine 55.5 ± 2.41 52.2 ± 2.0 52.9 ± 2.5 51.5 ± 2.2 
Tryptophan 1252.8·10
3 ± 226.4·103 1350.4·103 ± 74.54·103 787.1·103 ± 112.7·103* 1038.2·103 ± 169.9·103# 
Tyrosine 514.5 ± 63.3 382.6 ± 19.7 311.7 ± 71.89 * 274.6 ± 39.7* 
Valine 429.9 ± 46.7 455.3 ± 17.7 291.9 ± 61.1 290.8 ± 48.9 
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 Table 6. Mitochondrial morphometric analysis in liver tissue 
 
 
Mitochondrial density (Nmit/100 m2), mitochondrial area (Amit), and mitochondrial 
to cytoplasmic area (Amit/Acyt) ratio measured in liver tissue of the various 
experimental groups. Values are given as mean ± SD. * P < 0.05 vs CTRL, 
† 
P < 0.05 
vs. EtOH-fed animals. 
 
 
 
 
 
 
 
 Nmit/100m2 Amit Amit/Acyt 
CTRL 0.82 ± 0.14 12.32 ± 1.75 0.11 ± 0.02 
BCAAem 0.88 ± 0.17 13.48 ± 1.86 0.13 ± 0.03 
EtOH 0.52 ± 0.13 * 16.89 ± 4.1 * 0.08 ± 0.01 * 
EtOH+BCAAem 0.71 ± 0.11 26.12 ± 4.4 * 
†
 0.16 ± 0.03 
ANOVA F = 8.70; P = 0.0001 F = 65.95; P = 0.0001 F = 13.85; P = 0.0001 
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